Oxygen tension directs chondrogenic differentiation of myelo-monocytic progenitors during endochondral bone formation.

Synthesis of bone requires both essential progenitors to form the various structures and the correct microenvironment for their differentiation. To identify these factors, we have used a system that exploits bone morphogenetic protein's ability to induce endochondral bone formation rapidly. One of the earliest events observed was the influx and proliferation of fibroblastic cells that express both vascular smooth muscle cell markers, alpha smooth muscle actin (alpha SMA), smooth muscle myosin heavy chain, and the monocytic marker CD68. The expression of these factors was lost by days 4 to 5, coincident with the up-regulation of Sox9 and the appearance of chondrocytes. Studies with a cyclization recombination (Cre)/lox system, in which a myeloid-specific promoter driving Cre recombinase can irreversibly unblock expression of beta-galactosidase only in cells of myeloid origin, showed specific activity in the newly formed chondrocytes. These results suggest that early chondrocyte progenitors are of myeloid origin. Simultaneous with this recruitment, we determined that a numbers of these cells were in a hypoxic state, indicative of a low-oxygen environment. The cells in the hypoxic regions were undergoing chondrogenesis, whereas cells in adjacent normoxic regions appeared to be assembling into new vessels, suggesting that the oxygen microenvironment is critical for establishment of the cartilage.

[1]  S. Kato,et al.  Altered fracture callus formation in chondromodulin-I deficient mice. , 2008, Bone.

[2]  A. Davis,et al.  Efficient and rapid osteoinduction in an immune-competent host. , 2007, Human gene therapy.

[3]  C. Bäckesjö,et al.  Activation of Sirt1 Decreases Adipocyte Formation During Osteoblast Differentiation of Mesenchymal Stem Cells , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  E. Schipani.  Hypoxia and HIF‐1α in Chondrogenesis , 2006 .

[5]  J. Wozney.  Engineering new bone with bone morphogenic proteins. , 2006, Annales d'endocrinologie.

[6]  W. Sheu,et al.  Rosiglitazone inhibits endothelial proliferation and angiogenesis. , 2006, Life sciences.

[7]  N. McDonald,et al.  Assay of Bone Morphogenetic Protein-2, -4, and -7 in Human Demineralized Bone Matrix , 2006, The Journal of craniofacial surgery.

[8]  M. Frid,et al.  Circulating mononuclear cells with a dual, macrophage-fibroblast phenotype contribute robustly to hypoxia-induced pulmonary adventitial remodeling. , 2005, Chest.

[9]  A. Davis,et al.  Novel compound enables high-level adenovirus transduction in the absence of an adenovirus-specific receptor. , 2005, Human gene therapy.

[10]  C. Patterson,et al.  Bone morphogenetic proteins and vascular differentiation , 2005, Thrombosis and Haemostasis.

[11]  E. Martí,et al.  Morphogens in motion: growth control of the neural tube. , 2005, Journal of neurobiology.

[12]  B. Aronow,et al.  Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. , 2005, Bone.

[13]  Luigi Naldini,et al.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.

[14]  Di Chen,et al.  The BMP signaling and in vivo bone formation. , 2005, Gene.

[15]  Y. Bobryshev.  Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: implications for diffuse intimal calcification , 2005, The Journal of pathology.

[16]  K. Rubin,et al.  Inhibition of TGF-β modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma , 2005, Laboratory Investigation.

[17]  Xu Cao,et al.  BMP signaling in skeletal development. , 2005, Biochemical and biophysical research communications.

[18]  J. Wilcox,et al.  Peripheral Blood Mononuclear Cells Acquire Myofibroblast Characteristics in Granulation Tissue , 2005, Journal of Vascular Research.

[19]  C. Verfaillie.  Multipotent adult progenitor cells: an update. , 2005, Novartis Foundation symposium.

[20]  H. Shigemitsu,et al.  Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis , 2004, Current opinion in rheumatology.

[21]  Y. Tintut,et al.  Mesenchymal stem cells and the artery wall. , 2004, Circulation research.

[22]  M. Longaker,et al.  Transient Changes in Oxygen Tension Inhibit Osteogenic Differentiation and Runx2 Expression in Osteoblasts* , 2004, Journal of Biological Chemistry.

[23]  D. Persons,et al.  Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F. Camargo,et al.  Stem cell plasticity: from transdifferentiation to macrophage fusion , 2004, Cell proliferation.

[25]  W. Reith,et al.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.

[26]  A. Davis,et al.  Primitive adult hematopoietic stem cells can function as osteoblast precursors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Watson,et al.  Multilineage Potential of Cells From the Artery Wall , 2003, Circulation.

[28]  F. Camargo,et al.  Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates , 2003, Nature Medicine.

[29]  Y. Ikeda,et al.  Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation , 2003, Journal of leukocyte biology.

[30]  H. Rohrer.  The role of bone morphogenetic proteins in sympathetic neuron development. , 2003, Drug news & perspectives.

[31]  A. Davis,et al.  Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type , 2003, Gene Therapy.

[32]  A. Veis.  A Letter from the Editor: A New Era for Connective Tissue Research , 2003 .

[33]  M. McKee,et al.  Cartilage Formation and Calcification in Arteries of Mice Lacking Matrix Gla Protein , 2003, Connective tissue research.

[34]  J. Huard,et al.  Muscle-Derived Stem Cells , 2004, Gene therapy.

[35]  Marie-Christine Chaboissier,et al.  The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. , 2002, Genes & development.

[36]  A. Davis,et al.  Use of a chimeric adenovirus vector enhances BMP2 production and bone formation. , 2002, Human gene therapy.

[37]  M. Spector,et al.  Expression of smooth muscle actin in connective tissue cells participating in fracture healing in a murine model. , 2002, Bone.

[38]  Richard O C Oreffo,et al.  Bone tissue engineering: hope vs hype. , 2002, Biochemical and biophysical research communications.

[39]  A. Davis,et al.  Construction of adenoviral vectors , 2001, Molecular biotechnology.

[40]  A. Hoffmann,et al.  BMP signaling pathways in cartilage and bone formation. , 2001, Critical reviews in eukaryotic gene expression.

[41]  M Noda,et al.  SOX9 Enhances Aggrecan Gene Promoter/Enhancer Activity and Is Up-regulated by Retinoic Acid in a Cartilage-derived Cell Line, TC6* , 2000, The Journal of Biological Chemistry.

[42]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[43]  Reinhard Kuehn,et al.  Advances in gene targeting methods. , 1997, Current opinion in immunology.

[44]  R. Behringer,et al.  Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein , 1997, Nature.

[45]  K. Rajewsky.  Clonal selection and learning in the antibody system , 1996, Nature.

[46]  H. Wu,et al.  Interstitial myofibroblasts in experimental renal infection and scarring. , 1995, American journal of nephrology.

[47]  D. Simmons,et al.  Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. , 1993, Blood.

[48]  V. Paralkar,et al.  Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[49]  G P Nolan,et al.  Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Urist,et al.  Experimental myositis ossificans: cartilage and bone formation in muscle in response to a diffusible bone matrix-derived morphogen. , 1978, Archives of pathology & laboratory medicine.

[51]  A. J. Varghese,et al.  Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. , 1976, Cancer research.

[52]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.